Member Info for Uncanny

Lol, so the price in Dec 2017 didn't rise from 0.95p to 7.75p then?

Look for yourself, you found the other Dec RNS’s

And an RNS that 8 bagged the SP

401 -Company is pleased to now announce the positive formal data release pertaining to disease impact. The results demonstrate that the VAL401 treatment has a statistically significant improvement in Overall Survival ("OS") for patients with non-small cell lung cancer compared to those receiving no treatment.

An 8 bagger!

So what next chaps?

201 update - when? Can we hope for a repeat of Dec 2017 news?

What revaluation RB?

Roses roses roses - where is your real perspective!

No response then.

Love your candidness Valju - nail on the head!

Can’t respond to simple Q&A’s, so going back to you Roses for you to respond:

what is wrong below:

301 - reduction in legions by 30%
201 - 40% reduction at 4mg and slows metatistic growth
401 - suppression of cancer growth, not cure

So Roses please respond?

Ok roses, benefit of the doubt, what is wrong below:

301 - reduction in legions by 30%
201 - 40% reduction at 4mg and slows metatistic growth
401 - suppression of cancer growth, not cure

Are the compounds of VAL not on topic? Ffs

Come on!

Roses, all you do is talk this company down IMHO and yes much to criticise perhaps management but what positives do you agree with?

301 - reduction in legions by 30%
201 - 40% reduction at 4mg and slows metatistic growth
401 - suppression of cancer growth, not cure

No compound has been shelved because there are commercial opportunities.

Do you agree or perhaps you have a different spin?

Yes Gilders, but is that wrong if it suppresses growth?

Well said Hein

Gilders, well yes, take it for life or die l guess - l know what l’d do!

Thanks mate and agree, but hardly a pain killer like Roses purports!

Jayj4u on Advfn:

”Suzy will do something but you just have to wait and see.“

Don’t you think it sounds more like a cancer cure than a pain killer as you purport:

.”The absolute values obtained provide support for future studies of VAL401 as a cancer treatment, as the Cmax demonstrates sufficient exposure to reach the concentrations seen during preclinical anticancer testing,“

Do you really think the Euro Journal would let them publish duff info?

Factually correct and has to be from a regulatory perspective

Dont worry Roses , enjoy your dinner.